We are live on
!
Find out more
RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.7B
1-Year Est. Return
93.03%
This Fund
S&P 500
This Quarter
Est. Return
-12.12%
1 Year Est. Return
+93.03%
3 Year Est. Return
+228.43%
5 Year Est. Return
+368.14%
10 Year Est. Return
+4,607.77%
AUM
$1.23B
AUM Growth
-$138M
(-10%)
Cap. Flow
+$87.1M
Cap. Flow
% of AUM
7.07%
Top 10 Holdings %
Top 10 Hldgs %
28.99%
Holding
134
New
17
Increased
54
Reduced
20
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
STJ
St Jude Medical
STJ
|
+$37.8M |
| 2 |
AET
Aetna Inc
AET
|
+$26.5M |
| 3 |
Acadia Healthcare
ACHC
|
+$23.1M |
| 4 |
Teva Pharmaceuticals
TEVA
|
+$21.1M |
| 5 |
CHMA
Chiasma, Inc. Common Stock
CHMA
|
+$13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$42.2M |
| 2 |
Humana
HUM
|
+$25.2M |
| 3 |
THOR
THORATEC CORPORATION
THOR
|
+$24.5M |
| 4 |
Bausch Health
BHC
|
+$17.9M |
| 5 |
McKesson
MCK
|
+$16.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 76.04% |
| 2 | Financials | 3.43% |
| 3 | Technology | 0.48% |
| 4 | Industrials | 0.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Acadia Healthcare
ACHC
$2.55B
| $53.8M | 4.37% |
812,000
+300,250
| +59% | +$23.1M |
|
|
AET
2
DELISTED
Aetna Inc
AET
| $42.2M | 3.43% |
386,000
+229,500
| +147% | +$26.5M |
|
3
AbbVie
ABBV
$465B
| $40.6M | 3.3% |
746,423
| – | – |
|
|
RDUS
4
DELISTED
Radius Health, Inc.
RDUS
| $38.8M | 3.15% |
560,000
+131,000
| +31% | +$9.1M |
|
5
HCA Healthcare
HCA
$88.4B
| $37.9M | 3.08% |
490,500
+68,000
| +16% | +$6.02M |
|
|
AGN
6
DELISTED
Allergan plc
AGN
| $34.2M | 2.78% |
126,000
+4,500
| +4% | +$1.38M |
|
|
STJ
7
DELISTED
St Jude Medical
STJ
| $33.4M | 2.71% |
+530,000
| New | +$37.8M |
|
|
ALXN
8
DELISTED
Alexion Pharmaceuticals
ALXN
| $26.9M | 2.18% |
172,000
+17,500
| +11% | +$3.19M |
|
9
Gilead Sciences
GILD
$165B
| $25.3M | 2.05% |
257,500
| – | – |
|
10
Pfizer
PFE
$143B
| $23.9M | 1.94% |
801,040
| – | – |
|
|
MDCO
11
DELISTED
Medicines Co
MDCO
| $22.6M | 1.83% |
595,000
+249,500
| +72% | +$8.76M |
|
12
Collegium Pharmaceutical
COLL
$1.18B
| $22M | 1.78% |
994,400
+239,800
| +32% | +$4.34M |
|
|
CELG
13
DELISTED
Celgene Corp
CELG
| $21.4M | 1.74% |
198,000
| – | – |
|
|
EVHC
14
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $21M | 1.7% |
190,380
| – | – |
|
|
ONCE
15
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $20.9M | 1.69% |
500,000
-8,059
| -2% | -$421K |
|
|
16
Bausch Health
BHC
$1.75B
| $20.1M | 1.63% |
112,500
-76,750
| -41% | -$17.9M |
|
17
Eli Lilly
LLY
$1.08T
| $19.5M | 1.58% |
232,500
| – | – |
|
|
18
Teva Pharmaceuticals
TEVA
$40.4B
| $18.4M | 1.49% |
+325,000
| New | +$21.1M |
|
|
TMH
19
DELISTED
Team Health Holdings Inc
TMH
| $17M | 1.38% |
315,000
+2,500
| +0.8% | +$156K |
|
20
Intuitive Surgical
ISRG
$127B
| $16.5M | 1.34% |
324,000
+27,000
| +9% | +$1.53M |
|
21
Cigna
CI
$78.4B
| $16.5M | 1.34% |
122,000
| – | – |
|
22
Neurocrine Biosciences
NBIX
$18.2B
| $14.9M | 1.21% |
374,000
-2,000
| -0.5% | -$96.7K |
|
|
ADPT
23
DELISTED
Adeptus Health Inc
ADPT
| $14.4M | 1.17% |
178,000
+28,000
| +19% | +$2.89M |
|
|
HTWR
24
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $14.3M | 1.16% |
273,000
+111,000
| +69% | +$8.43M |
|
|
INOV
25
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $14.3M | 1.16% |
685,000
+125,000
| +22% | +$2.9M |
|
Similar funds
AAM
SGI
ACM
BCM
ISS
PP
FDP
GAM
Rock Springs Capital Management's Q3 2015 Portfolio in Review
As of Q3 2015, Rock Springs Capital Management held 134 positions worth $1.23B, down 10% from $1.37B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Rock Springs Capital Management deployed $87.1M of net new capital in Q3 2015, opening 17 new positions and adding to 54 existing holdings. Its largest new stake was St Jude Medical: 530,000 shares worth $33.4M.
By sector, the portfolio is most concentrated in Healthcare at 76% of assets, down from 77% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was THORATEC CORPORATION, an estimated $24.5M trimmed.
- Rock Springs Capital Management's largest Q3 2015 buy was St Jude Medical: 530,000 shares worth $33.4M.
- Rock Springs Capital Management added most to Aetna Inc in Q3 2015, an estimated $26.5M increase.
- Rock Springs Capital Management's biggest Q3 2015 reduction was THORATEC CORPORATION, cutting an estimated $24.5M.
- Rock Springs Capital Management fully exited Medtronic in Q3 2015, selling an estimated $42.2M.
- Rock Springs Capital Management's ten largest holdings make up 29% of its $1.23B portfolio in Q3 2015.
- Rock Springs Capital Management opened 17 new positions and closed 13 in Q3 2015.
- Rock Springs Capital Management's portfolio value fell 10% quarter-over-quarter to $1.23B.
Based on Rock Springs Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.